Shealy Jeffrey B. 4
4 · Palomino Laboratories Inc. · Filed Oct 27, 2025
Insider Transaction Report
Form 4
Shealy Jeffrey B.
DirectorPresident and CEO10% Owner
Transactions
- Sale
Warrants
2025-09-29$1.20/sh+833,333$1,000,000→ 4,666,666 totalExercise: $1.50From: 2025-09-29→ Common Stock (833,333 underlying) - Other
Common Stock
2025-09-29+3,833,333→ 4,666,666 total
Footnotes (1)
- [F1]Per the terms of an Agreement and Plan of Merger, dated September 29, 2025, Palomino Acquisition Co., a subsidiary of Issuer, merged into Rhino Subsidiary Inc. (f/k/a Palomino Laboratories Inc., "Pre-Merger Palomino"). Mr. Shealy, as a shareholder of Pre-Merger Palomino, received 3,000,000 shares of common stock, par value $0.0001 per share, of Issuer ("Common Stock") in exchange for his Pre-Merger Palomino shares. On September 29, 2025, Issuer closed a private placement offering and, in connection therewith, Mr. Shealy converted his SAFEs into 833,333 Units in the offering at a price of $1.20 per Unit. Each Unit consists of one share of the Common Stock and one warrant to purchase one share of Common Stock at an exercise price of $1.50. The warrants expire on the first anniversary of the date the Common Stock is admitted for trading or listed on an Approved Market (as defined in the warrant agreement).